Author

Neil Swanson

Observed names: N E I L Swanson, N M Swanson, N Swanson, N. Swanson, Neil M.G. Swanson, Neil SWANSON, Swanson, Neil

Institutions: University Hospital of North Tees, James Cook University Hospital, South Tees Hospitals NHS Foundation Trust, The Rotherham NHS Foundation Trust

Observed institutions: University of Leicester, University Hospital of North Tees, James Cook University Hospital, Waikato Hospital, Glenfield Hospital, University Hospitals of Leicester NHS Trust, South Tees Hospitals NHS Foundation Trust, Sorbonne Université, Assistance Publique – Hôpitaux de Paris, The Rotherham NHS Foundation Trust, Hôpital Saint-Antoine, Waikato District Health Board

OpenAlex ID: A5033249686

2024 ESC Guidelines for the management of chronic coronary syndromes

2024 · Christiaan Vrints, Felicita Andreotti, et al. · European Heart Journal · 3,459

Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial

2019 · Deepak L Bhatt, Philippe Gabriel Steg, et al. · The Lancet · 212

Primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction: changing patterns of vascular access, radial versus femoral artery

2009 · S L Hetherington, Z Adam, et al. · Heart · 127

Viability and Outcomes With Revascularization or Medical Therapy in Ischemic Ventricular Dysfunction

2023 · Divaka Perera, Matthew Ryan, et al. · JAMA Cardiology · 96

PDF

Vascular endothelial growth factor (VEGF)-eluting stents: in vivo effects on thrombosis, endothelialization and intimal hyperplasia.

2003 · Neil Swanson, Kai Hogrefe, et al. · PubMed · 60

Primary percutaneous balloon pericardiotomy for malignant pericardial effusion

2008 · Neil Swanson, Intisar Mirza, et al. · Catheterization and Cardiovascular Interventions · 54

Delay to angiography and outcomes following presentation with high-risk, non-ST-elevation acute coronary syndromes: results from the Global Registry of Acute Coronary Events

2008 · N Swanson, G Montalescot, et al. · Heart · 48

Effect of Pre-Hospital Ticagrelor During the First 24 h After Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction

2016 · Gilles Montalescot, Arnoud W. van ’t Hof, et al. · JACC: Cardiovascular Interventions · 47

PDF

Arrhythmia and Death Following Percutaneous Revascularization in Ischemic Left Ventricular Dysfunction: Prespecified Analyses From the REVIVED-BCIS2 Trial

2023 · Divaka Perera, Holly P. Morgan, et al. · Circulation · 37

PDF

Impact of Anatomical and Viability-Guided Completeness of Revascularization on Clinical Outcomes in Ischemic Cardiomyopathy

2024 · Saad M. Ezad, Margaret McEntegart, et al. · Journal of the American College of Cardiology · 35

In vitro evaluation of vascular endothelial growth factor (VEGF)-eluting stents

2003 · Neil Swanson, Kai Hogrefe, et al. · International Journal of Cardiology · 30

Tumor Necrosis Factor-α Antibody Eluting Stents Reduce Vascular Smooth Muscle Cell Proliferation in Saphenous Vein Organ Culture

2002 · Qamar Javed, Neil Swanson, et al. · Experimental and Molecular Pathology · 22

Effect of PCI on Health Status in Ischemic Left Ventricular Dysfunction

2024 · Matthew Ryan, Dylan Taylor, et al. · JACC Heart Failure · 19

Human internal mammary artery organ culture model of coronary stenting: a novel investigation of smooth muscle cell response to drug-eluting stents

2002 · Neil SWANSON, Qamar JAVED, et al. · Clinical Science · 12

Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction: Cost-Effectiveness Analysis of the REVIVED-BCIS2 Trial

2023 · Carlos Chivardi, Holly Morgan, et al. · Circulation Cardiovascular Quality and Outcomes · 10

PDF

Semaglutide and Hospitalizations in Patients With Obesity and Established Cardiovascular Disease

2025 · Stephen J. Nicholls, Donna H. Ryan, et al. · JAMA Cardiology · 8

Current perspectives on British use of adjunctive therapies during coronary interventions

2001 · Neil Swanson, Kai Hogrefe, et al. · International Journal of Cardiology · 8

Rapid Aspirin Desensitization is Safe and Feasible in Patients With Stable and Unstable Coronary Artery Disease: A Single-Center Experience

2019 · Matthew Jackson, Sarah Callaghan, et al. · Journal of Cardiovascular Pharmacology and Therapeutics · 6

Drug Eluting Stents in Interventional Cardiology - Current Evidence and Emerging Uses

2005 · N. Swanson, A. Gershlick · Cardiovascular & Haematological Disorders - Drug Targets · 6

The SSTARS (STeroids and Stents Against Re-Stenosis) Trial: Different stent alloys and the use of peri-procedural oral corticosteroids to prevent in-segment restenosis after percutaneous coronary intervention

2016 · Z. Adam, A. Turley, et al. · International Journal of Cardiology · 5

Sarcoidosis presenting with tachy- and brady-arrhythmias

2007 · Neil Swanson, Martin Goddard, et al. · EP Europace · 5

PDF

Long-term Mortality After Primary Percutaneous Coronary Intervention for High-risk Myocardial Infarction

2009 · Neil M.G. Swanson, Gerry P. Devlin, et al. · Heart Lung and Circulation · 4

Two-year clinical results of a polymer-free, paclitaxel-eluting stent: the ELUTES trial.

2007 · Neil Swanson, Ivan De Scheerder, et al. · PubMed · 4

Eptifibatide-eluting stent as an antiproliferative and antithrombotic agent: in vitro evaluation.

2006 · Kamal Chitkara, Kai Hogrefe, et al. · PubMed · 4

Door to balloon times: streamlining admission for primary percutaneous coronary intervention.

2010 · Neil Swanson, Christopher Nunn, et al. · PubMed · 3

Works count: 58

Citation count: 4,344

H-index: 13

I10-index: 15